# Asher Chanan‐Khan

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/asher-chanan-khan/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,728 |
| Field | Chronic Lymphocytic Leukemia Research |
| h-index | 70 |
| i10-index | 249 |
| Last Known Institution | WinnMed |
| OpenAlex ID | https://openalex.org/A5010286156 |
| ORCID iD | https://orcid.org/0000-0002-4702-6772 |
| Works | 659 |

## Researcher papers

- [Randomized Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen Sodium (Bcl-2 antisense) in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia](https://scholariq.org/papers/randomized-phase-iii-trial-of-fludarabine-plus-cyclophosphamide-with-or-without/)
- [Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial](https://scholariq.org/papers/pembrolizumab-plus-pomalidomide-and-dexamethasone-for-patients-with-relapsed-or/)
- [Cancer- and Chemotherapy-Induced Anemia](https://scholariq.org/papers/cancer-and-chemotherapy-induced-anemia/)

## Researcher topics

- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)

## Researcher university

- [WinnMed](https://scholariq.org/institutions/winnmed/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.